# BIVALIRUDIN

NDC: 71288-427
Generic name: BIVALIRUDIN
Labeler / Manufacturer: Meitheal Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20180716

FDA application: ANDA091602

## Active ingredients

- BIVALIRUDIN: 250 mg/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71288-427"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71288-427
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4119b710-ef30-4e3e-b99a-38e42b4b3fca